Literature DB >> 24047529

Microglia and neuropathic pain.

Håkan Aldskogius1, Elena N Kozlova.   

Abstract

Neuropathic pain is a serious consequence of injury or disease in the nervous system itself. Current treatment options for this condition are often unsatisfactory. From being originally viewed as a diseased caused by neuronal dysfunction, a growing body of evidence implicate activated microglia as a key player in the development of this pain condition. In this review, some of the evidence for this proposal is briefly discussed and placed in a translational context, pointing out the difficulties in translating commonly used animal models of neuropathic pain to the clinical condition, as well as emphasizing the broader role of activated microglia in the injured or diseased nervous system.

Entities:  

Mesh:

Year:  2013        PMID: 24047529     DOI: 10.2174/18715273113126660168

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  7 in total

Review 1.  Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.

Authors:  Zhi-Jun Zhang; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

2.  Anti-allodynic effect of intrathecal processed Aconitum jaluense is associated with the inhibition of microglial activation and P2X7 receptor expression in spinal cord.

Authors:  Jihoon Yang; Keun Suk Park; Jae Joon Yoon; Hong-Beom Bae; Myung Ha Yoon; Jeong Il Choi
Journal:  BMC Complement Altern Med       Date:  2016-07-13       Impact factor: 3.659

Review 3.  ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain.

Authors:  Ramona D'Amico; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

4.  Caffeic acid phenethyl ester attenuates neuropathic pain by suppressing the p38/NF-κB signal pathway in microglia.

Authors:  Hao Cheng; Yong Zhang; Weiping Lu; Xianzhong Gao; Chenjie Xu; Hongguang Bao
Journal:  J Pain Res       Date:  2018-11-01       Impact factor: 3.133

5.  P2Y6 Receptor-Mediated Spinal Microglial Activation in Neuropathic Pain.

Authors:  Jiang Bian; Ying Zhang; Yan Liu; Qun Li; Hai-Bin Tang; Qing Liu
Journal:  Pain Res Manag       Date:  2019-06-03       Impact factor: 3.037

6.  Exploring the Correlation Between the Regulation of Macrophages by Regulatory T Cells and Peripheral Neuropathic Pain.

Authors:  Hongyu Chen; Liangfu Jiang; Dupiao Zhang; Jianpeng Chen; Xiaobin Luo; Yutong Xie; Tao Han; Liang Wang; Zhe Zhang; Xijie Zhou; Hede Yan
Journal:  Front Neurosci       Date:  2022-02-14       Impact factor: 4.677

7.  Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.

Authors:  Hong-Qiang Qiu; Ying Xu; Gui-Lin Jin; Jian Yang; Ming Liu; Su-Ping Li; Chang-Xi Yu
Journal:  Mol Pain       Date:  2015-08-09       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.